Form 4: Agilysys CFO Sells Shares Under 10b5-1 Plan

Agilysys Chief Financial Officer William David Wood III sold 584 shares of common stock for $125.2 per share as part of a pre-arranged trading plan.

Summary

• Agilysys Inc.'s Chief Financial Officer, William David Wood III, reported a sale of common stock.
• The transaction involved the disposition of 584 shares of Agilysys common stock.
• The shares were sold at a price of $125.2 per share.
• The total value of the shares sold was approximately $73,116.80.
• The transaction occurred on November 4, 2025.
• This sale was executed pursuant to a Rule 10b5-1(c) trading plan, indicating it was pre-scheduled.
• Following this transaction, William David Wood III beneficially owns 41,052 shares of Agilysys common stock directly.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to an officer selling shares, even though it was part of a pre-planned 10b5-1 arrangement, which mitigates the negative impact compared to an unplanned sale.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, which suggests the sale was pre-scheduled and not based on new, non-public information, potentially mitigating negative investor sentiment.

Negatives

• An officer selling shares, even under a 10b5-1 plan, can sometimes be interpreted by investors as a signal of reduced confidence in the company's near-term prospects, although the amount sold is relatively small.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders may interpret the insider sale as a slight negative signal, potentially influencing their perception of management's confidence in the company, although the 10b5-1 plan context reduces this impact.

Key Dates

Keywords

Agilysys, AGYS, Insider Trading, Form 4, Stock Sale, CFO, 10b5-1 Plan, Beneficial Ownership